Yuankai Shi

The global implications of diabetes and cancer

Yuankai Shi, Frank B. Hu · The Lancet · 2014 · 425 citations

Obesity, Metabolic Syndrome, Diabetes Management +8

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada et al. · Journal of Clinical Oncology · 2017 · 414 citations

Advanced-stage Dlbcl, Lymphoid Neoplasia, Hematological Malignancy +13

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

Mei Dong, Zhiqiang Ning, Pu-yuan Xing et al. · Cancer Chemotherapy and Pharmacology · 2012 · 120 citations

Lymphoid Neoplasia, Oncology, Medicine +6

miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer

Lin Lin, Haibo Lin, Lin Wang et al. · Oncology Reports · 2015 · 56 citations · Full text